Industry Background:
Hair loss and growth devices refer to the range of equipment such as laser band, laser cap and LEDs that are meant to treat hair loss. These devices help to reduce the effect of hair loss rather as hair losses are irreversible. As per the American department of Dermatology, over 80 million men and women are suffering from hair loss problems in the United States alone. Growing phenomena of hair loss across the globe provide a great opportunity for hair loss and growth devices manufacture to innovate through their products and focus and developing effective products amid high bargaining power of consumers.
According to AMA Research, the market for Hair Loss and Growth Devices is expected to register a CAGR of 6.6% during the forecast period to 2030. This growth is primarily driven by Rising Cases of Hair fall Owing to Changing Lifestyle
.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Forecast Period | 2024-2030 |
Volume Unit | K Units |
Value Unit | USD (Million) |
Customization Scope | Avail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility |
The Pharmaceuticals sector in the
region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Procter & Gamble (United States), Johnson & Johnson Consumer (United States), TRX2 (United States), Toppik (United States), Merck (United States), Shiseido (Japan), Henkel (Germany), Lifes2Good (Ireland), Gerolymatos International (Greece), Unilever (U.K.), Nanogen (United States), DS Healthcare Group (United States), Avalon Natural Products (United States), Bayer (Germany), Taisho Pharmaceutical Co., Ltd. (Japan), Rohto Pharmaceutical (Japan), Yanagiya (Japan), Pharma Medico (United Kingdom), Keranique (United States) and Phyto (India), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.
Key Developments in the Market:
In May 2022,Unilever announced today that it has signed an agreement to acquire a majority stake in Nutrafol, a leading provider of hair wellness products. Unilever currently holds a minority stake (13.2%) in Nutrafol through Unilever Ventures
In Nov 2017, the Premium Skincare brand Vichy cosmetics has launched its own anti hair loss treatment product containing five active ingredients for both men and women in Malta. The product claims to rebalance and recreate a healthier scalp for hair growth.
Influencing Trend:
Growing Demand for Organic and Natural Products and Celebrity Endorsement and Effective Branding Strategy by Manufacturing
Market Growth Drivers:
Rising Cases of Hair fall Owing to Changing Lifestyle and Growing Geriatrics Population Across the World
Challenges:
Negative Perception Related with Effectiveness of these Products and Dominance of Local Manufacturers
Restraints:
High Cost of Hair Care Devices and Availability of Alternate Hair Care Products
Opportunities:
Rising Disposable Income in Low and Middle-Income Countries and Effective Branding Through Digital Channels
AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.
Data Sources of Hair Loss and Growth Devices Market Study
Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Hair Loss and Growth Devices Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.
The primary interviews and data collected as per the below protocols:
By Designation: C-Level, D-Level, Others
By Company Type: Tier 1, Tier 2, Tier 3
Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Hair Loss and Growth Devices players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.
Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
Against this Challenging Backdrop, Hair Loss and Growth Devices Study Sheds Light on
The Hair Loss and Growth Devices Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Hair Loss and Growth Devices industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
Where Hair Loss and Growth Devices industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.